Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,070Revenue (TTM) $M748Net Margin (%)13.0Altman Z-Score2.1
Enterprise Value $M1,121EPS (TTM) $1.3Operating Margin %17.3Piotroski F-Score7
P/E(ttm)11.8Beneish M-Score-3.0Pre-tax Margin (%)17.3Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %6.2Current Ratio1.2Lower Leverage y-yY
Price/Free Cash Flow9.0y-y EBITDA Growth Rate %-9.5ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %--PEG1.9ROE % (ttm)13.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M68.4ROIC % (ttm)15.8Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNKen Fisher 2016-12-31 Reduce$16.26 - $21.35
($18.09)
$ 15.66-13%Reduce -35.34%59,731
MYGNFirst Eagle Investment 2016-09-30 Sold Out -0.03%$19.7 - $32.49
($25.36)
$ 15.66-38%Sold Out0
MYGNJoel Greenblatt 2016-09-30 Add0.02%$19.7 - $32.49
($25.36)
$ 15.66-38%Add 16.88%421,728
MYGNMario Gabelli 2016-09-30 Sold Out -0.01%$19.7 - $32.49
($25.36)
$ 15.66-38%Sold Out0
MYGNKen Fisher 2016-09-30 Add$19.7 - $32.49
($25.36)
$ 15.66-38%Add 0.16%92,381
MYGNRon Baron 2016-09-30 Buy $19.7 - $32.49
($25.36)
$ 15.66-38%New holding40,000
MYGNJoel Greenblatt 2016-06-30 Add0.06%$29.12 - $39.5
($34.78)
$ 15.66-55%Add 79.05%360,830
MYGNFirst Eagle Investment 2016-06-30 Buy 0.03%$29.12 - $39.5
($34.78)
$ 15.66-55%New holding368,980
MYGNKen Fisher 2016-06-30 Add$29.12 - $39.5
($34.78)
$ 15.66-55%Add 2.73%92,236
MYGNKen Fisher 2016-03-31 Add$34.12 - $43.16
($37.75)
$ 15.66-59%Add 0.01%89,783
MYGNJoel Greenblatt 2016-03-31 Add$34.12 - $43.16
($37.75)
$ 15.66-59%Add 2.63%201,527
MYGNJoel Greenblatt 2015-12-31 Buy 0.09%$37.77 - $46.16
($42.36)
$ 15.66-63%New holding196,364
MYGNKen Fisher 2015-09-30 Add$30.94 - $41.39
($35.43)
$ 15.66-56%Add 1.96%89,775
MYGNJoel Greenblatt 2015-03-31 Sold Out -0.16%$32.63 - $39.49
($35.79)
$ 15.66-56%Sold Out0
MYGNKen Fisher 2015-03-31 Reduce$32.63 - $39.49
($35.79)
$ 15.66-56%Reduce -0.32%88,050
MYGNMario Gabelli 2015-03-31 Buy $32.63 - $39.49
($35.79)
$ 15.66-56%New holding25,000
MYGNJoel Greenblatt 2014-12-31 Reduce-0.11%$32.01 - $39.49
($35.44)
$ 15.66-56%Reduce -34.58%568,865
MYGNKen Fisher 2014-12-31 Buy 0.01%$32.01 - $39.48
($35.39)
$ 15.66-56%New holding88,333
MYGNJoel Greenblatt 2014-09-30 Reduce-0.12%$35.44 - $40.41
($37.28)
$ 15.66-58%Reduce -22.18%869,531
MYGNFirst Eagle Investment 2014-06-30 Sold Out -0.026%$33.1 - $42.21
($37.11)
$ 15.66-58%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HENDERSON JOHN TDirector 2016-09-12Sell30,000$20.49-23.57view
Capone Mark ChristopherPresident & C.E.O. 2016-08-19Buy10,000$21.24-26.27view
McDade Ralph LPresident Myriad RBM, Inc. 2016-08-12Buy1,000$21.49-27.13view
Ford AlexanderPresident, MGL 2016-06-21Sell18,637$30.87-49.27view
King Gary A.Exec. VP International Ops 2016-04-06Sell15,000$39.03-59.88view
King Gary A.Exec. VP International Ops 2016-04-01Sell15,000$38.12-58.92view
GILBERT WALTER PHDDirector 2015-12-11Sell5,000$42.23-62.92view
Phanstiel S. LouiseDirector 2015-12-08Sell5,000$44-64.41view
DREISMANN HEINRICHDirector 2015-11-05Sell60,000$44.44-64.76view
MARSH RICHARD ME.V.P., General Counsel 2015-11-04Sell35,000$44.5-64.81view

Quarterly/Annual Reports about MYGN:

News about MYGN:

Articles On GuruFocus.com
Casualty List Has Done Well; Here’s the Latest Jan 18 2017 
Industrial Companies Showing Good Potential for 2017 Jan 04 2017 
Gurus and Insiders Invest in Industrial and Medical Companies Dec 30 2016 
Chuck Royce Reduces Several Positions in 4th Quarter Feb 05 2016 
Chuck Royce Comments on Myriad Genetics Oct 08 2014 
Chuck Royce’s Royce Premier Fund Second Quarter 2014 Manager Commentary Oct 08 2014 
Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
Surfing for Billionaire Bargains Sep 22 2013 
Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 

More From Other Websites
Casualty List Has Done Well; Here's the Latest Jan 18 2017
Coverage initiated on Myriad Genetics by Deutsche Bank Jan 18 2017
Myriad Genetics: Evidence Street Reviews EndoPredict Test Jan 06 2017
The EndoPredict® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield... Jan 06 2017
The EndoPredict® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield... Jan 06 2017
Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : January 5,... Jan 05 2017
EndoPredict® Reviewed by Blue Cross Blue Shield Association's Evidence Street Jan 05 2017
EndoPredict® Reviewed by Blue Cross Blue Shield Association’s Evidence Street Jan 05 2017
Industrial Companies Showing Good Potential for 2017 Jan 04 2017
Gurus and Insiders Invest in Industrial and Medical Companies Dec 30 2016
MYRIAD GENETICS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Dec 28 2016
Myriad Genetics' Unit Releases Favorable Data on Vectra DA Dec 28 2016
Myriad Genetics to Present at the 2017 JP Morgan Healthcare Conference Dec 28 2016
Medicare Decisions For Myriad Present A Mixed Bag Dec 27 2016
Positive Clinical Utility Results of Crescendo’s Vectra® DA Test for Rheumatoid Arthritis... Dec 27 2016
Myriad Genetics: United Rheumatology Selects Vectra DA Test Dec 23 2016
United Rheumatology Issues Clinical Practice Guidelines and Recommends the Vectra® DA Test for... Dec 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)